Abstract
Cryosurgery can be used to treat pre-malignant and malignant skin conditions. Actinic keratosis (AK) is a pre-malignant proliferation of keratinocytes manifesting as erythematous, scaly papules or plaques on sun-exposed skin. Two types of therapy are need for AK: lesion directed, to destroy individual AK and field, to destroy perilesional, microscopic changes. Lesion directed therapies include electrodessication and curettage, excision, and laser ablation. Field physical modalities include photodynamic therapy (PDT), peels, and laser resurfacing. Cryosurgery, a lesion directed therapy, is very successful and is one of the most commonly employed treatments for AK. Bowen’s disease presents as a well-defined, hyperkeratotic plaque; therapeutic options include PDT, curettage, topical 5-FU, excision, laser ablation, radiotherapy and cryosurgery. Malignant lesions treatable with cryosurgery include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Excision is the most commonly used therapy for them. Alternatives include electrodessication and curettage, radiation, PDT, topical 5-FU and imiquimod. Cryosurgery for BCC and SCC shows success rates that rival excision when performed by a trained physician.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol. 2013;68(1 Suppl 1):S28–38.
Berman B, Goldenberg G, Hanke CW, et al. Efficacy and safety of ingenol mebutate 0.015 % gel after cryosurgery of actinic keratosis: 12-month results. J Drugs Dermatol. 2014;13(6):741–7.
Schwartz RA, Bridges TM, Butani AK, Ehrlich A. Actinic keratosis: an occupational and environmental disorder. J Eur Acad Dermatol Venereol. 2008;22(5):606–15.
Simon JC, Dominicus R, Karl L, Rodríguez R, Willers C, Dirschka T. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5 % 5-fluorouracil in combination with 10.0 % salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis. J Eur Acad Dermatol Venereol. 2015;29(5):881–9.
Ianhez M, Miot HA, Bagatin E. Liquid nitrogen for the treatment of actinic keratosis: a longitudinal assessment. Cryobiology. 2014;69(1):140–3.
Butani A, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg. 2005;32(2):223–35.
Micali G, Nasca MR, Innocenzi D, Schwartz RA. Penile cancer. J Am Acad Dermatol. 2006;54(3):369–1.
Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists’ guidelines for the management of squamous cell carcinoma in situ (Bowen’s disease). Br J Dermatol. 2014;170(2):245–60.
Bahner JD, Bordeaux JS. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013;31(6):792–8.
Lindgren G, Larkö O. Cryosurgery of eyelid basal cell carcinomas including 781 cases treated over 30 years. Acta Ophthalmol. 2014;92(8):787–92.
Rodríguez VG, De la Fuente GA, Torres MAC, Flores MG, Moreno GJ, Candiani JO. Could cryosurgery be an alternative treatment for basal cell carcinoma of the vulva? Indian Dermatol Online J. 2014;5(2):160–3.
Smith V, Walton S. Treatment of facial basal cell carcinoma: a review. J Skin Cancer. 2011;2011:380371.
Barrett TL, Smith KJ, Hodge JJ, Butler R, Hall FW, Skelton HG. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J Am Acad Dermatol. 1997;37(3):430–7.
Dlugosz A, Agrawal S, Kirkpatrick P. Vismodegib. Nat Rev Drug Discov. 2012;11(6):437–8.
Micali G, Lacarrubba F, Nasca MR, Ferraro S, Schwartz RA. Topical pharmacotherapy for skin cancer: part ll. Clinical applications. J Am Acad Dermatol. 2014;70(6):979.e971–912; quiz 9912.
Micali G, Lacarrubba F, Nasca MR, Schwartz RA. Topical pharmacotherapy for skin cancer: part 1. Pharmacology. J Am Acad Dermatol. 2014;70(6):965.e961–912; quiz 977–8.
Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–50.
Kuflik EG. Cryosurgery for cutaneous malignancy: an update. Dermatol Surg. 1997;23(11):1081–7.
Thai K-E, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol. 2004;43(9):687–92.
Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis. 2014;94(5):255–9.
Jorizzo JL, Markowitz O, Lebwohl MG, et al. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratosis. J Drugs Dermatol. 2010;9(9):1101–8.
Holt PJA. Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol. 1988;119(2):231–40.
Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg. 2004;30(2):297–300.
Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.
Kuflik EG. Cryosurgery updated. J Am Acad Dermatol. 1994;31(6):925–44.
Suhonen E, EGK R. Cryosurgical methods for eyelid lesions. J Dermatol Treat. 2001;12(3):135–9.
Kuflik EG, Gage AA. Recurrent basal cell carcinoma treated with cryosurgery. J Am Acad Dermatol. 1997;37(1):82–4.
Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol. 1991;24:1002–4.
Zacarian SA. Cryosurgery of cutaneous carcinomas: an 18-year study of 3,022 patients with 4,228 carcinomas. J Am Acad Dermatol. 1983;9:947–56.
Graham GF, Clark LC. Statistical analysis in cryosurgery of skin cancer. In: Breitbart EW, Dachow-Siwiec E, editors. Clinics in dermatology: advances in cryosurgery. New York: Elsevier; 1990.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag London
About this chapter
Cite this chapter
Singh, P., Stone, R.C., Schwartz, R.A., Micali, G. (2016). Cryosurgery for Premalignant and Malignant Skin Conditions. In: Abramovits, W., Graham, G., Har-Shai, Y., Strumia, R. (eds) Dermatological Cryosurgery and Cryotherapy. Springer, London. https://doi.org/10.1007/978-1-4471-6765-5_127
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6765-5_127
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6764-8
Online ISBN: 978-1-4471-6765-5
eBook Packages: MedicineMedicine (R0)